Predictors of recurrence in ER positive breast cancer include tumor and nodal stage at presentation, tumor grade, measures of proliferation such as Ki67, quantitative degrees of ER/PR expression, intrinsic subtype, and molecular diagnostic profiles. This evidence concerns the gene MKI67 and neoplasm.